3D printing Report

The market for 3D bioprinting will reach $1.9 billion by 2028

3D Bioprinting 2018 - 2028: Technologies, Markets, Forecasts

Opportunities in cosmetics and consumer product testing, drug development and regenerative medicine


 
Table of Contents
1.EXECUTIVE SUMMARY
1.1.Overview
1.2.Key 3D Bioprinter Manufacturers
1.3.3D Bioprinting Service Bureaus
1.4.High Profile Partnerships
1.5.3D Bioprinter Market Forecast 2018 - 2028
1.6.3D Bioprinted Tissue Market Forecast 2018 - 2028
1.7.Key Drivers
1.8.Key Challenges
2.INTRODUCTION
2.1.Report Scope / 3D Bioprinting Definition
2.2.3D Bioprinting Process
2.3.3D Bioprinting Process: Discussion
2.4.3D Cell Culture Advantages
2.5.3D Bioprinting Advantages
2.6.Key Driver: Regenerative Medicine
2.7.Key Driver: Unmet Need in Organs for Transplant
2.8.Key Driver: Product Testing in Medicine
2.9.Key Driver: Avoiding Costly Drug Trial Failures
2.10.Key Driver: Product Testing in Consumer Products
2.11.Major Bioprinting Firsts
2.12.Key Trends: 3D Bioprinters
2.13.Key Trends: Bioprinted Tissues
2.14.Key Competing Technologies
2.15.Current Biological Challenges
2.16.Regulatory Hurdles
2.17.3D Bioprinting SWOT Analysis
3.3D BIOPRINTER TECHNOLOGIES
3.1.From 3D Printing to 3D Bioprinting
3.2.3D Bioprinting Technologies
3.3.Comparison of Key Specifications
3.4.3D Bioprinting Technology Comparison
3.5.Inkjet: Introduction
3.6.Inkjet: Key Specifications
3.7.Inkjet: Thermal
3.8.Inkjet: Piezoelectric
3.9.Inkjet: Advantages
3.10.Inkjet: Challenges
3.11.Inkjet: SWOT Analysis
3.12.Extrusion: Introduction
3.13.Extrusion: Key Specifications
3.14.Extrusion: Pneumatic
3.15.Extrusion: Mechanical
3.16.Extrusion: Advantages
3.17.Extrusion: Challenges
3.18.Extrusion: SWOT Analysis
3.19.Laser: Introduction
3.20.LIFT: Key Specifications
3.21.LIFT: Laser-Induced Forward Transfer
3.22.LIFT: Advantages
3.23.LIFT: Challenges
3.24.LIFT: SWOT Analysis
3.25.Microvalve: Introduction
3.26.Microvalve: Key Specifications
3.27.Microvalve: Solenoid
3.28.Microvalve: Advantages
3.29.Microvalve: Challenges
3.30.Microvalve: SWOT Analysis
3.31.Other Technologies
3.32.Microfluidic Chip
3.33.In-Air Microfluidics
3.34.Turnstile
3.35.Microneedle Array
3.36.2-Photon Polymerization
3.37.Cell Electrospinning
3.38.Microscale Continuous Optical Bioprinting
3.39.Paramagnetic and Acoustic
3.40.Industry-wide Technical Challenges
3.41.The Ideal 3D Bioprinter
3.42.Future Technological Directions
4.RELATED TECHNOLOGIES
4.1.Related Technologies
4.2.3D Bioprinting Software
4.3.Bioink Preparation
4.4.Cell Selection
4.5.Cell Selection: Regenerative Medicine
4.6.Cell Selection: Bacteria
4.7.Growth Factors and Other Additives
4.8.Matrix Materials
4.9.Matrix Materials: Companies
4.10.The Ideal Scaffold Material
4.11.Cell Spheroid Printing
4.12.Maturation
5.APPLICATIONS
5.1.Introduction
5.2.Testing of Cosmetics and Other Consumer Goods
5.3.Testing of Cosmetics and Other Consumer Goods: Skin
5.4.Drug Screening
5.5.Drug Screening: Drug Development Process
5.6.Drug Screening: Benefits of 3D Bioprinting
5.7.Drug Screening: Cancer
5.8.Personalised Medicine
5.9.Regenerative Medicine
5.10.Regenerative Medicine: Tissue Roadmap
5.11.Regenerative Medicine: Bone and cartilage
5.12.Regenerative Medicine: Skin
5.13.Regenerative Medicine: Dental
5.14.Regenerative Medicine: Vasculature
5.15.Regenerative Medicine: Complex Organs
5.16.Regenerative Medicine: Mini-Organs
5.17.Cell-Based Biosensors
5.18.Food and Other Animal Products
5.19.Education
5.20.Academic Research
5.21.Bionics
6.MARKETS AND FORECASTS
6.1.Introduction
6.2.Growing 3D Bioprinting Market
6.3.Key 3D Bioprinter Manufacturers
6.4.3D Bioprinting Service Bureaus
6.5.High Profile Partnerships
6.6.Research Groups and Centers
6.7.Market Barriers
6.8.Key Losers
6.9.Forecasts
6.10.Overall 3D Bioprinting Market Forecast 2018 - 2028
6.11.Overall 3D Bioprinting Market Forecast: Short and Long Term
6.12.3D Bioprinting Value Chain
6.13.3D Bioprinting Value Chain: Discussion
6.14.3D Bioprinter Manufacturers
6.15.3D Bioprinters by Cost and Technology
6.16.3D Bioprinter Market Forecast 2018 - 2028
6.17.3D Bioprinter Market Forecast: Short Term
6.18.3D Bioprinter Market Forecast: Long Term
6.19.3D Bioprinted Tissue Forecast 2018 - 2028
6.20.3D Bioprinted Tissue Forecast: Consumer Products
6.21.3D Bioprinted Tissue Forecast: Pharmaceuticals
6.22.3D Bioprinted Tissue Forecast: Others
7.REGENERATIVE MEDICINE
7.1.Introduction
7.2.Regulatory Hurdles
7.3.Regenerative Medicine Advanced Therapy Designation
7.4.RMAT: 1 year Later
7.5.Ethics
7.6.Scams and Schemes
7.7.From Lab to Clinic
7.8.3D Bioprinting Roadmap to 2050
8.APPENDIX
8.1.List of Abbreviations
8.2.List of 3D Bioprinting Companies
9.LIST OF COMPANY PROFILES
9.1.3D Bioprinting Solutions/Vivax Bio
9.2.3Dynamic Systems
9.3.Aether
9.4.Aspect Biosystems
9.5.BioBots (now Allevi)
9.6.BioDan Group
9.7.BIOLIFE4D
9.8.Cellbrick
9.9.Cellenion
9.10.Cellink
9.11.Digilab
9.12.GeSiM
9.13.Microdrop Technologies
9.14.MicroFab Technologies
9.15.Organovo
9.16.PeptiGelDesign
9.17.Poietis
9.18.Prellis Biologics
9.19.Regemat 3D
9.20.regenHu
9.21.SE3D
9.22.Sichuan Revotek

Subscription Enquiry

X